Research Article

Characterization of the PMT Gene Family in Cryptococcus neoformans

  • Sven D. Willger mail,

    Affiliations: Institut für Mikrobiologie, Molekulare Mykologie, Heinrich-Heine-Universität, Düsseldorf, Germany, Department of Veterinary Molecular Biology, Montana State University, Bozeman, Montana, United States of America

  • Joachim F. Ernst,

    Affiliation: Institut für Mikrobiologie, Molekulare Mykologie, Heinrich-Heine-Universität, Düsseldorf, Germany

  • J. Andrew Alspaugh,

    Affiliation: Departments of Medicine and Molecular Genetics/Microbiology, Duke University Medical Center, Durham, North Carolina, United States of America

  • Klaus B. Lengeler

    Affiliation: Institut für Mikrobiologie, Molekulare Mykologie, Heinrich-Heine-Universität, Düsseldorf, Germany

  • Published: July 27, 2009
  • DOI: 10.1371/journal.pone.0006321



Protein-O-mannosyltransferases (Pmt's) catalyze the initial step of protein-O-glycosylation, the addition of mannose residues to serine or threonine residues of target proteins.

Methodology/Principal Findings

Based on protein similarities, this highly conserved protein family can be divided into three subfamilies: the Pmt1 sub-family, the Pmt2 sub-family and the Pmt4 sub-family. In contrast to Saccharomyces cerevisiae and Candida albicans, but similar to filamentous fungi, three putative PMT genes (PMT1, PMT2, and PMT4) were identified in the genome of the human fungal pathogen Cryptococcus neoformans. Similar to Schizosaccharomyces pombe and C. albicans, C. neoformans PMT2 is an essential gene. In contrast, the pmt1 and pmt4 single mutants are viable; however, the pmt1/pmt4 deletions are synthetically lethal. Mutation of PMT1 and PMT4 resulted in distinct defects in cell morphology and cell integrity. The pmt1 mutant was more susceptible to SDS medium than wild-type strains and the mutant cells were enlarged. The pmt4 mutant grew poorly on high salt medium and demonstrated abnormal septum formation and defects in cell separation. Interestingly, the pmt1 and pmt4 mutants demonstrated variety-specific differences in the levels of susceptibility to osmotic and cell wall stress. Delayed melanin production in the pmt4 mutant was the only alteration of classical virulence-associated phenotypes. However, the pmt1 and pmt4 mutants showed attenuated virulence in a murine inhalation model of cryptococcosis.


These findings suggest that C. neoformans protein-O-mannosyltransferases play a crucial role in maintaining cell morphology, and that reduced protein-O-glycosylation leads to alterations in stress resistance, cell wall composition, cell integrity, and survival within the host.


Protein-O-glycosylation is an essential, evolutionary conserved protein modification that has been studied extensively in the yeasts Saccharomyces cerevisiae and Candida albicans. This process has also been identified in other fungal species [1][3], in higher eukaryotes [4][6] and in certain bacterial genera [7], [8]. In yeasts and fungi, protein-O-glycosylation is initiated at the luminal side of the endoplasmic reticulum (ER) by the addition of a mannosyl residue to specific serine/threonine residues of proteins entering the secretory pathway [9], [10]. This first modification is derived from the polyisoprenoid carrier lipid dolichyl phosphate-activated mannose (Dol-P-Man), followed by the addition of short, linear, mannosyl-rich glycans. Maturation and further modification of the glycosyl chains occur in the Golgi apparatus.

The initial step of O-glycosylation is catalysed by a highly conserved family of integral ER membrane proteins, the protein-O-mannosyltransferases (Pmt's) [11]. The Pmt family was initially identified in S. cerevisiae, in which seven PMT genes have been identified [3], [11]. Broader phylogenetic analyses reveal that protein-O-mannosyltransferases can be grouped into three major subfamilies, corresponding to S. cerevisiae Pmt1p, Pmt2p and Pmt4p. Many fungal species contain only three PMT genes in their genome, one for each subfamily.

In S. cerevisiae, O-glycosylation affects the stability, localization, and function of proteins, preventing the exportation of misfolded proteins from the ER [12][14]. Similarly, in the human pathogenic fungus C. albicans, correct O-mannosylation is important for morphogenesis, adherence to host cells, and virulence [15]. C. albicans proteins that are modified by Pmt's include chitinases, proteases, proteins involved in glucan synthesis, heat-shock proteins, and cell-surface antigens important for virulence (reviewed in [2], [3]). In addition to secreted proteins, the proper function of various receptors requires intact protein-O-glycosylation activity [14], [16].

Although protein-O-mannosylation seems to be less abundant in higher eukaryotes, defects in this process result in human disease, such as muscle-eye-brain disease (MEB) and Walker–Warburg Syndrome (WWS) [17]. Furthermore, a targeted deletion of POMT1, which causes WWS in mice resulted in embryonic lethality [18]. Mutation of Drosophila PMT homologs alters muscle structures and the alignment of adult cuticle [19], [20]. Therefore, the analysis of the PMT-gene family in different species over the last few years revealed that protein-O-mannosylation activity is involved in central developmental and growth processes in both uni- and multicellular eukaryotes.

C. neoformans is an opportunistic human fungal pathogen causing life-threatening meningoencephalitis. This fungus produces several extracellular factors that are important for virulence, including an extensive polysaccharide capsule, several secreted hydrolytic enzymes, and the cell wall-targeted pigment melanin (reviewed in [21]). Since protein-O-glycosylation predominantly affects extracellular proteins, any defect in this biological process may affect the interface of pathogenic microorganism and the host.

PMT4, one of three putative Pmt orthologs in the basidiomycete C. neoformans, has recently been identified. Disruption of the C. neoformans PMT4 gene results in dramatic effects on virulence [22]. In addition, pmt4 mutant strains show morphological defects and alterations of the cell wall, possibly due to changes in glycan composition/synthesis. However, the relative roles of C. neoformans PMT1 and PMT2 have not yet been elucidated. In this paper we report a continuing analysis of the complete C. neoformans PMT gene family in two biologically distinct varieties, var. grubii and var. neoformans. We identified three C. neoformans PMT genes, and we have begun to define their overlapping and distinct functions in stress response, cell wall integrity, and survival in the host.


Three PMT genes are present in C. neoformans

Fungal genomes typically contain multiple genes encoding protein-O-mannosyltransferases. For example, S. cerevisiae contains seven PMT genes (PMT1-7), while five PMT genes are present in the genome of the human pathogenic fungus C. albicans. Three putative PMT genes were recently identified in the basidiomycetous yeast C. neoformans variety neoformans (serotype D), one for each major sub-family: PMT1 (CND06150 on chromosome 4), PMT2 (CNJ01930 on chromosome 10), and PMT4 (CND01240 on chromosome 4) [23]. C. neoformans Pmt1 shares 41% amino acid identity and 59% similarity to S. cerevisiae Pmt1; CnPmt2 has 47% identity and 65% similarity to ScPmt2; and CnPmt4 has 42% identity and 61% similarity to ScPmt4. Beyond direct amino acid sequence comparison, a more detailed phylogenetic sequence analysis places each of the three C. neoformans PMT genes into one of the three major PMT gene families. Hydrophobicity analysis of the predicted Pmt protein sequences revealed a seven-transmembrane helical structure commonly predicted for this class of proteins [9].

Although closely related, C. neoformans var. neoformans and var. grubii strains (serotypes D and A, respectively) have distinct characteristics in terms of intracellular signaling and cellular physiology [24][26]. As scientific models, var. grubii strains have been used most extensively in pathogenesis experiments, and var. neoformans strains have more tractable mating and genetic systems. The three PMT genes are also present in the var. grubii genome, encoding proteins that are 97–98% identical at the amino acid level to those from var. neoformans. For clarity, we have chosen to refer to the var. grubii (serotype A) PMT genes as PMT1A, PMT2A, and PMT4A; and the var. neoformans (serotype D) genes as PMT1D, PMT2D, and PMT4D.

PMT genes of C. neoformans are constitutively expressed under various growth conditions

We characterized the transcriptional regulation of the entire C. neoformans PMT gene family under various physiologically relevant growth conditions. The wild-type strains JEC21 (serotype D) and H99 (serotype A) were incubated to mid-logarithmic phase in rich medium (YPD) at 30°C and 37°C, salt stress (YPD+1 M NaCl), and capsule-inducing conditions (DMEM). Northern blots and quantitative real-time PCR demonstrated little variation in the expression of any of the three PMT genes in either strain variety under these conditions (data not shown). Therefore, the three C. neoformans PMT genes are constitutively expressed under most growth conditions. Our data support and confirm the recent observation that the PMT4A gene is not induced by changes in temperature or nutrient availability [22].

Protein-O-glycosylation is essential in C. neoformans

We used targeted gene disruption to further characterise the biological functions of the C. neoformans PMT genes in both serotype backgrounds. Since it has been shown in other organisms that pmt mutant strains can be highly sensitive to cell wall destabilizing drugs and drugs targeting protein synthesis, including those used in C. neoformans as dominant selectable markers (such as hygromycin B), we used the ADE2 and URA5 genes as selectable markers to perform these experiments. The selectable marker cassettes were inserted into the loop five region of the PMT genes, which is predicted to be essential for enzyme function [27].

While pmt1 and pmt4 single mutant strains could easily be isolated for both serotypes, we were not able to isolate pmt2 mutant strains from either serotype, even after several rounds of transformation (>300 transformants). This finding suggested that PMT2 might be an essential gene in C. neoformans, as it is in S. pombe and C. albicans [15], [28]. To further confirm this hypothesis, we isolated a homozygous ade2/ade2 diploid strain from a cross of strains JEC156 (MATa ade2 ura5) and JEC157 (MATalpha ade2 ura5 lys1) according to the methods of Sia et al. [29]. By transforming a pmt2::ADE2 disruption construct into this diploid strain, we were able to isolate heterozygous PMT2/pmt2::ADE2 strains at similar frequencies (~10%) compared to the pmt1 and pmt4 single mutants. We then allowed three independent heterozygous diploid mutants to sporulate. From this sporulation, we isolated 75 ADE+haploid progeny, and all had a wild-type PMT2 locus. In contrast, the other genetic markers (mating type, LYS1) demonstrated expected levels of recombination. We assume that the ADE+progeny that are not pmt2, either have an ectopic integration of pmt2::ADE or have a recombination that restores the ade2 allele back to wild-type. To determine that the isolated 75 ADE+haploid progeny had a wild-type PMT2 locus we first performed Southern Blot analyses on the diploid strains that were sporulated showing that the PMT2 and pmt2::ADE2 alleles were present (data not shown). The progeny were subsequently also analyzed by colony PCR for the nature of the PMT2 allele present in the strains amplifying a short fragment spanning the region where the ADE2 marker was integrated (data not shown). The failure to isolate haploid pmt2 mutants from the sporulation of the PMT2/pmt2 diploid strongly suggests that the PMT2 gene is essential.

To verify that the insertion of the selectable marker cassette resulted in a loss of the transcript for the pmt1 and pmt 4 mutants we performed real time PCRs with PMT1, PMT2, and PMT4 specific primers on cDNA derived from the serotype D mutants grown at 30°C. As a control we used cDNA derived from the serotype D wild-type strain JEC21. Since we couldn't generate a pmt2 mutant we normalized the data for each strain to the PMT2 expression. The results confirm that the PMT genes are constitutively expressed with only little to no variation in the wild-type strain JEC21 (Figure 1). In the insertion mutants the transcript of either PMT1 or PMT4 is completely abolished in the respective mutant. The real time PCR data also clearly show that none of the PMT genes is differentially expressed in any of the mutants to compensate the loss of another PMT gene (Figure 1).


Figure 1. PMTs are not differentially expressed and the loss of one pmt gene is not compensated by overexpression of another PMT gene.

The wild-type (JEC21), Δpmt1 and Δpmt4 mutant strains were incubated to mid-logarithmic phase in YPD medium and total RNA was isolated. Quantitative real-time PCR was performed on the corresponding cDNA samples to assess relative PMT1, PMT2, and PMT4 transcript abundance compared to the wild-type strain±one standard deviation. The expression values in all three strains are normalized to the PMT2 expression.


The “Pmt holoenzyme” functions as a dimer or multimer of the individual Pmt proteins

It has been shown for other yeasts that Pmt2 forms a heterodimer with Pmt1 proteins and that these dimers show a high protein-O-mannosylation activity [28], [30]. Based on this finding and interaction studies of Pmts in higher eukaryotes, i.e. in human, where POMT1 (member of the PMT4 family) and POMT2 (member of the PMT2 family) form heterodimers [31], we predicted that in Cryptococcus Pmt2 also forms heterodimers with other Pmts. This model of protein function would predict that the pmt1 pmt4 double mutation would be synthetically lethal since there would be no other Pmt protein to interact with Pmt2. To test this hypothesis, we crossed the MATalpha pmt1D strain with the MATa pmt4D strain and isolated individual basidiospores by microdissection. We tested the resulting progeny strains for the following genetic markers: mating type, PMT1, PMT4, ADE2, and URA5. The marker segregation pattern demonstrated that the isolated spores were the result of meiotic recombination (Figure 2). More importantly, among the 15 dissected spores we were not able to identify a pmt1 pmt4 double mutant, strongly suggesting that the pmt1 and pmt4 mutations are synthetically lethal. These results suggest that protein-O-glycosylation is an essential process in C. neoformans, and that either Pmt1 and Pmt4 both interact with Pmt2 to provide the cell with optimal protein-O-mannosylation activity or that Pmt1 and Pmt4 have a common essential target independent of Pmt2.


Figure 2. A pmt1 pmt4 double deletion is lethal in serotype D.

Serotype D strains pmt1D (MATa pmt1D::URA5 ade2-27) and pmt4D (MATα pmt4D::ADE2 ura5) were crossed on standard V8 mating media and individual spores were isolated after several days by micromanipulation. A: 15 individual progeny were analyzed by colony PCR for the presence of the PMT1 (upper panel) and PMT4 alleles (lower panel). Position of the respective wild-type and disruption alleles are indicated at right. Wild-type strain JEC21 was used as a control. B: The 15 strains from A were spotted onto the indicated plates, grown for 2–3 days at 30°C and subsequently analyzed for auxotrophic marker distribution. Strains were spotted from top left (#1) to bottom right (wild-type control). C: Summary of the genotypes identified in A and B with respect to PMT alleles and mating-type. Mating-type of the individual spores were determined by standard mating reactions using wild-type strains JEC20 (MATa) and JEC21 (MATα) as tester strains.


pmt1 and pmt4 mutant strains show altered cell morphology

For other yeasts and filamentous fungi, the loss of certain protein-O-mannosyltransferases results in cell morphology defects. In contrast to wild-type cells that grow as single yeasts with simple buds, the C. neoformans pmt4A and pmt4D mutant strains both exhibited a cell aggregation phenotype when cells were grown for 24 h to 48 h in either YPD or SD medium at 30°C. The cells were often associated in multi-cell aggregates (Figure 3A). In addition, the cell aggregates could not be resolved by vortexing or sonication suggesting that the Δpmt4 strain may have a defect in cell separation, rather than altered cell adherence (Figure 3B). Calcofluor white staining of cell wall chitin in the pmt4 mutant strains demonstrated a failure of daughter cells to separate properly from mother cells, with unusually large amounts of cell wall chitin in this area (Figure 4, arrow). These results confirmed recently published data on another pmt4A mutant in which cell aggregates were still connected by un-degraded cell wall material as demonstrated by transmission electron microscopy [22]. Moreover, since each single cell retained a single nucleus shown by DAPI staining (Figure 4) there seems to be no obvious effect of the pmt4 mutation on the cell cycle.


Figure 3. The pmt1 and pmt4 disruption strains show altered cell morphology.

A: Serotype A wild-type strain H99 and mutant strains pmt1A (pmt1A::URA5) and pmt4A (pmt4A::URA5) were incubated in YPD at 30°C and 37°C to an OD600 of 1, and cells were subsequently analyzed by light microscopy (DIC). B: Serotype A pmt4A strain was incubated in YPD at 30°C to an OD600 of 1, and cell suspension was analyzed by light microscopy (DIC) after no treatment or 1 min vortexing or sonication.


Figure 4. pmt1 and pmt4 mutant strains show altered cell wall phenotypes and vacuole distribution.

Wild-type serotype A strain H99 and pmt mutant strains pmt1A (pmt1A::URA5) and pmt4A (pmt4A::URA5) were incubated in YPD at 30°C to an OD600 of 1. Cells were fixed for 30 min in 10% formaldehyde and subsequently stained as described with chitin staining dye calcofluor white, the DNA dye DAPI and the vacuolar dye FM4-64. Pictures were taken at 400x using a Zeiss Axioskop 2 Plus Fluorescence Microscope and a AxioCam MRM digital camera.


In contrast to the pmt4 mutant strains, the pmt1A and pmt1D mutants did not show prominent cell aggregation when grown under the same conditions (Figure 3A), and calcofluor white staining revealed a normal pattern of chitin deposition and cell separation (Figure 4). When incubated at 37°C, the pmt1 and pmt4 mutants demonstrated prominent morphological changes compared to wild type. Both mutants grew as large, dysmorphic cells subject to spontaneous lysis. Although DAPI staining revealed single nuclei in all strains, the nuclei in the pmt1 and pmt4 mutants were often displaced to the cell periphery by a large central structure. This structure was demonstrated to be an enlarged vacuole by staining with FM4-64 (Figure 4). Although the large vacuole is present in these cells at 30°C, it is most prominent in cells incubated at 37°C. In contrast, wild-type cells displayed multiple, small vacuoles when incubated at similar conditions.

The pmt mutants are sensitive to different cell stresses

Pmt proteins play important roles in cell wall architecture, and mutations in these proteins often result in increased sensitivity to various cell stresses such as elevated growth temperature, osmotic stress or cell wall destabilising agents. Consistent with the temperature-dependent cell morphology changes in the pmt mutants, both pmt1A and pmt4A strains displayed a marked defect in growth at elevated temperatures (Figure 5). When incubated on YPD medium at 30°C, both mutant strains grew similar to wild type. However, at 37°C, both pmt mutants displayed reduced colony size, consistent with a profound temperature-sensitive growth defect (Figure 5). Formal growth curves, measuring changes in the optical density of log-phase cultures in a liquid YPD, confirmed the observations on solid media (data not shown). In contrast to the wild type and reconstituted strains, neither mutant strain grew at 39°C (Figure 5). The pmt1D and pmt4D mutant strains displayed a similar but less severe temperature-dependent growth defect.


Figure 5. pmt mutant strains show growth defects at high growth temperatures.

Over-night cultures of wild-type, pmt mutant and corresponding reconstituted strains from serotype A (upper panel) and serotype D (lower panel) were adjusted to an OD600 of 0.1 and diluted by 10-fold serial dilutions down to a 10−4 dilution. 5 µl of each dilution step was spotted onto YPD plates, and plates were incubated at the indicated temperature for 2–3 days. Strains used were the serotype A strains H99 (wild-type), pmt1A (pmt1A::URA5), pmt4A (pmt4A::URA5), pmt1A+PMT1A (pmt1A::URA5 PMT1A-NeoR) and pmt4A+PMT4A (pmt4A::URA5 PMT4A-NeoR), and the respective serotype D strains JEC21 (wild-type), pmt1D (pmt1D::URA5), pmt4D (pmt4D::URA5), pmt1D+PMT1D (pmt1D::URA5 PMT1D-NeoR) and pmt4D+PMT4D (pmt4D::URA5 PMT4D-NeoR).


The pmt mutant strains of both serotypes also displayed increased susceptibility to salt stress (Figure 6 A). When incubated in the presence of 0.5 M KCl, the pmt4A and pmt4D strains grew slower than wild-type/reconstituted strains. Both pmt4 mutant strains also demonstrated striking growth inhibition by the addition of 0.7 M or 1 M NaCl to the medium (Figure 6A). The pmt1A and pmt1D strains were also inhibited by NaCl, but to a lesser extent than the pmt4 strains. The cell wall destabilising agents Congo red, caffeine, and calcofluor white had no significant effect on the growth of the pmt mutants in either variety (data not shown).


Figure 6. pmt mutant strains are sensitive to hyper-osmotic stresses.

Over-night cultures of wild-type, pmt mutant and corresponding reconstituted strains from serotype A (upper panel) and serotype D (lower panel) were adjusted to an OD600 of 0.1 and diluted by 10-fold serial dilutions down to a 10−4 dilution. 5 µl of each dilution step was spotted onto YPD plates containing stress agents, and plates were incubated at the indicated temperature for 2–3 days. Strains used were the serotype A strains H99 (wild-type), pmt1A (pmt1A::URA5), pmt4A (pmt4A::URA5), pmt1A+PMT1A (pmt1A::URA5 PMT1A-NeoR) and pmt4A+PMT4A (pmt4A::URA5 PMT4A-NeoR), and the respective serotype D strains JEC21 (wild-type), pmt1D (pmt1D::URA5), pmt4D (pmt4D::URA5), pmt1D+PMT1D (pmt1D::URA5 PMT1D-NeoR) and pmt4D+PMT4D (pmt4D::URA5 PMT4D-NeoR). Strains were spotted onto YPD plates supplemented with various salts (A), sorbitol (B) or SDS (C) at indicated concentrations. To test G418 resistance (20 µg/ml) (C), over night cultures were initially diluted to an OD600 of 1.0 versus 0.1 used in all other experiments. Plates were incubated at 30°C for 2–3 days.


In contrast to the concordant effects of salt and temperature on the various pmt mutants in the two different varieties, the pmt1 and pmt4 mutants demonstrated variety-specific differences in the levels of susceptibility to other osmotic and cell wall stress. The pmt4A mutant is more susceptible than the corresponding pmt1A strain to sorbitol (2 M and 2.5 M) (Figure 6B), and the pmt1A mutant is more susceptible to the effects of 0.1% SDS (Figure 6C). In contrast, the pmt1D mutant grows very poorly in the presence of sorbitol (Figure 6B), but its growth is unaffected by SDS (Figure 6C). The pmt4D strain is not inhibited by high sorbitol concentrations, in contrast to the corresponding pmt4A strain; however, the growth of pmt4D is inhibited by SDS. Therefore, sorbitol and SDS have very different cell surface destabilizing effects on the pmt mutants in the two C. neoformans varieties, suggesting that the Pmt proteins play distinct roles in these related but divergent strain backgrounds.

Virulence factors of C. neoformans are differentially affected by the pmt mutations

Besides its ability to grow at 37°C, virulence of the fungal pathogen C. neoformans is determined by a set of specific virulence factors, including the secretion of various hydrolytic enzymes, the ability to produce a polysaccharide capsule, and the expression of the antioxidant melanin pigment. A common feature of these factors is the involvement of extracellular components. Since protein glycosylation mainly affects extracellular or surface-exposed proteins, we hypothesized that some of these virulence factors would be affected by mutations in genes affecting protein-O-mannosylation. Compared to wild type, the pmt1 and pmt4 mutants demonstrated no changes in the activity of the secreted enzymes urease or phospholipase B (data not shown), both of which have been linked to virulence of C. neoformans.

Another secreted protein that is essential for virulence of C. neoformans is the enzyme laccase, a phenoloxidase that catalyses the rate-limiting step of melanin production. While pmt1 mutant strains did not show any defect in melanin production, our pmt4 mutants (both serotype A and serotype D) were delayed in melanin production. The melanin production delay was complemented in the pmt4+PMT4 reconstituted strain (Figure 7). This finding contrasts with the prior observation of melanin production in a serotype A pmt4 mutant [22]. This difference may be due to small differences of the disruption constructs used in both studies (see Discussion).


Figure 7. pmt4 but not pmt1 mutant strains are delayed in melanin synthesis.

A: 10 µl of over-night cultures from serotype A strains H99 (wild-type), pmt1A (pmt1A::URA5), pmt4A (pmt4A::URA5) and pmt4A+PMT4A (pmt4A::URA5 PMT4A-NeoR) were spotted onto standard Niger seed-plates, and plates were incubated for three days at 30°C. B: Cells from 2 ml of the over-night cultures from A were harvested and resuspended in 2 ml glucose-free asparagine-medium supplemented with L-DOPA, and cultures were shaken at 30°C over night. Subsequently cells were pelleted, and cell pellet and supernatant were photographed. C: OD480 of the supernatants from cultures in B were determined and graphically displayed using Prism 5 (GraphPad, San Diego, Calif.). Graph shows the overall result of several independent experiments.


Another virulence-associated phenotype of C. neoformans is its ability to produce a large polysaccharide capsule. Using a standard India ink counter-stain, we assessed capsule formation in each of our pmt mutant strains. Microscopic analyses of the various serotype A and D mutant strains revealed that all strains made capsule when incubated in DMEM capsule-inducing medium. To control for cell size variation between the mutant and wild-type cells, we quantified relative capsule size by determining the total cell diameter of cells with the surrounding capsule compared to the diameter of the cell itself [32]. The average capsule ratio for 100 wild-type cells was 1.8 (+/−0.02), and this ratio was similar in the pmt1 mutant 1.75+/−0.05). In contrast, the capsule ratio for the pmt4 mutant was 1.45+/−0.03, indicative of a slightly reduced capsule size (data not shown). Results were identical for serotype A and serotype D strains, and the reduction in capsule size of the pmt4 strains was complemented by the wild-type PMT4 allele.

Protein-O-mannosylation and mating

The effect of Pmt's on mating was analyzed in the serotype D strains since these crosses are more vigorous than in serotype A, and since mating type has been associated with virulence in this strain background [33], [34]. The pmt1 mutant strains did not show any obvious defect in any unilateral (wild-type x pmt1) or bilateral (pmt1 x pmt1) crosses. In contrast, the pmt4 mutation showed notable effects on mating. Unilateral matings of the pmt4 strains to wild-type testers behaved similar to wild-type control crosses (data not shown). On the other hand, a bilateral cross of two pmt4 strains revealed a delayed mating reaction, with reduced filament formation after 48 h in comparison to wild-type controls (Figure 8). In addition, less aerial hyphae were produced during this cross, as indicated by the lack of the white mycelial rim surrounding the mating patch (Figure 8; small picture). Microscopic analysis of the hyphal structures produced in a bilateral pmt4 mating reaction showed irregularly shaped and thickened filaments with swollen distal tips, phenotypes reminiscent of mutations in the swoA locus of Aspergillus nidulans, a gene that interestingly has recently been found to encode one of three PMT genes present in A. nidulans [35].


Figure 8. pmt4D mutant strains show serotype-dependent filamentation defects.

To perform matings of wild-type and pmt mutant strains, the respective strains were first grown over-night in YPD at 30°C. Cells were harvested, washed twice with sterile 0.9% saline, and incubated in saline on a shaker for one hour at 30°C. 10 µl of respective strains were mixed, and the cells were spotted onto standard solid V8 agar plates, which were subsequently incubated at RT in the dark. Edges from the colonies and colonies themselves (small pictures) were photographed after 48 h. Shown are bilateral matings of serotype D strains JEC20 and JEC21 (wild-type), SW5 (MATa) and SW6 (MATα) (pmt1D mutants), and SW8 (MATa) and SW9 (MATα) (pmt4D mutants), respectively.


pmt mutant strains are severely attenuated for virulence

Considering the effect of the different pmt mutations on growth and virulence-associated phenotypes, it seemed likely that these mutations would also have a negative effect on virulence of C. neoformans. We therefore tested the pathogenicity of the serotype A strains in isolated macrophages and in whole animals. When co-incubated with activated J774A.1 macrophages, the pmt1A and pmt4A strains demonstrated reduced survival at 24 hours compared to wild-type (6-fold and 40-fold reduction, respectively) (Figure 9). These relative differences in macrophage survival are likely due to differences in high-temperature growth and virulence factor expression.


Figure 9. pmt mutant strains of serotype A are attenuated for virulence.

A: A macrophage killing assay was performed for the serotype A wild-type strain H99 and the pmt mutant strains SW13 (pmt1A::URA5) and SW14 (pmt4A::URA5) as previously described. CFU from two independent experiments with four repetitions of each strain are shown. B: A murine inhalation model was performed for serotype A strains H99 (wild-type), pmt1A (pmt1A::URA5), pmt4A (pmt4A::URA5), pmt1A+PMT1A (pmt1A::URA5 PMT1A-NeoR) and pmt4A+PMT4A (pmt4A::URA5 PMT4A-NeoR) as previously described. Briefly, for each strain 10 A/Jcr mice were infected intranasally with 105 CFU, and survival time post infection was determined.


In a murine model of inhaled cryptococcosis, both mutant strains were also significantly reduced in virulence. In this model, 105 C. neoformans colony-forming units are intranasally inoculated into complement-defective A/Jcr mice, simulating the natural respiratory route of infection in humans. Animals infected with either wild-type or reconstituted strains had a median survival of 18–19 days, and no mice survived past 21 days after infection. The median survival of mice infected with the pmt4A mutant was 40 days (p<0.001 compared to wild-type), and no mice infected with the pmt1A strain died from the infection during the course of the 45-day experiment (Figure 9).


Over the past few years, the Pmt-mediated process of protein-O-glycosylation has been defined in several species. Pmt's primarily modify proteins targeted for secretion, and this process is essential in most fungi [3], [28], [36]. Its role in fungal pathogenesis has also been explored in C. albicans and C. neoformans [22], [37]. In this report, we extend prior studies of Pmt function in the human pathogenic yeast C. neoformans. First, we demonstrated that C. neoformans contains three PMT genes, and that each gene encodes one Pmt enzyme for each of the major classes of these proteins. In contrast, other fungi such as S. cerevisiae have undergone paralogous duplication of PMT genes within these classes, perhaps developing novel functions for various Pmt proteins.

In addition to a conservation of sequence similarity in PMT genes, we also demonstrated that the basic function of C. neoformans Pmt enzymes is likely similarly conserved. For example, current models of Pmt enzyme activity suggest that the Pmt holoenzymes function optimally as heterodimers [28], [30], [38], and the activity of the Pmt2 class of proteins is a required component of these protein complexes [15], [28]. Consistent with this working model developed in other fungi, we demonstrated that the PMT2 gene is essential for viability in C. neoformans. Additionally, the simultaneous mutation of the C. neoformans PMT1 and PMT4 genes seems to be synthetically lethal, as predicted from a model in which Pmt2 must function in concert with other Pmt proteins. Such functional conservation suggests that strategies that block fungal Pmt function might inhibit the growth of diverse fungal species.

Besides being an essential process, we also demonstrated that protein-O-glycosylation has a significant effect on the virulence of C. neoformans, even in instances in which it is not required for viability. We demonstrated that mutations in either the PMT1 or PMT4 genes result in dramatic attenuation in virulence in both a macrophage killing assay and a mouse inhalation model of cryptococcosis, two models that assess different aspects of cryptococcal pathogenesis. Our studies in the role of Pmt4 on C. neoformans pathogenesis are consistent with prior reports [22]. However, these experiments demonstrate that the pmt1 mutant is even more attenuated for survival in vivo compared to pmt4 mutants, despite similar in vitro temperature- and cell wall-sensitive phenotypes. Interestingly, both pmt1 and pmt4 mutants show high temperature sensitivity at 39°C, which may have a great impact on infectivity in the mouse model. To investigate the role of temperature sensitivity in the virulence attenuation we will test the virulence of these mutants in a heterologous host model, such as wax moths (Galleria mellonella), which does not require high temperature during infection.

Virulence of the basidiomycete C. neoformans has been linked to several well-defined phenotypes, including the production and export of extracellular factors such as melanin, capsule, and various lytic enzymes [39][43]. Of these classic virulence-associated phenotypes, only melanin production was altered in one of these strains, the pmt4 mutant. C. neoformans strains that are defective in melanin production are attenuated for virulence, including strains with mutations in the laccase gene LAC1, encoding the rate limiting enzyme of melanin production [39], [40]. Therefore, the delay in melanin production likely plays a role in the reduced virulence of the pmt4 mutant strain.

The C. neoformans laccase Lac1 may also be a direct target of Pmt4. Lac1 is an N-glycosylated, cell wall associated protein [44], and N-glycosylation often precedes O-glycosylation. Altered Pmt4 activity might therefore lead to a mislocalization of Lac1 and a dramatic reduction of melanin production. Our observation of reduced melanin in the serotype A and D pmt4 mutants is different from a prior report in which no melanin defect was observed in a serotype A pmt4 mutant [22]. One difference between the two pmt4 mutants was the method of gene mutation. Between the 5th and 6th transmembrane domains, Pmt proteins are characterized by an extensive loop 5 that is essential for mannosyl-transferase activity [27]. Loop 5 contains three conserved motifs (A–C) that are important for enzyme activity, and domain C is the most C-terminal domain of this region of the protein. Olson et al. disrupted Pmt4 downstream of motif C; in contrast, our pmt4 mutations resulted at least in deletion of domain C in loop 5, supposedly resulting in complete inactivation of the Pmt4 enzyme.

In addition to the melanin delay, the pmt1 and pmt4 mutant cells display aberrant cell morphology and pronounced cell aggregation. These morphological changes may be linked to the cell wall- and temperature-sensitive phenotypes identified in vitro, resulting in cell lysis under stress. Similarly, hyperflocculant and dysmorphic C. neoformans cells demonstrated reduced virulence in a mouse model, as well as increased susceptibility to complement-activated phagocytosis by macrophages [45].

The temperature sensitivity of the pmt1 and pmt4 mutants likely explains much of the altered virulence in these strains. Other C. neoformans strains with altered growth at mammalian physiological temperatures display similar, predictable virulence defects [46]. Interestingly, in serotype A strains, but not in serotype D, the pmt1 mutant showed a significant growth defect at 37°C in liquid medium but not on solid medium. The differential growth effect in liquid medium may be caused by higher shearing forces that are not present during growth on a solid medium.

Moreover, previous reports demonstrated that pmt4 deficient strains showed dramatic differences in the overall pattern of mannosylated proteins by 2D gel electrophoresis [22]. Extracellular mannoproteins are important regarding immunological aspects of C. neoformans-host interactions including T-cell activation [47][49]. Therefore, defects in protein-O-glycosylation may also impair virulence of C. neoformans by altering the immunological response to the microbial cells and thereby affect pathogenesis. It therefore will be very interesting to analyze whether the pmt1 mutation results in similar differences in cell wall mannoprotein composition and which proteins are specifically affected by the pmt1 and pmt4 mutation. The identification of immediate targets for individual cryptococcal Pmt proteins may provide further explanations for the defects in pathogenicity found for the pmt1 and pmt4 mutants of C. neoformans.

Targets of the Pmt enzyme complex have been defined in various fungal species. In fact, the Fks1 protein may be modified by C. neoformans Pmt4 [22]. Since Fks1 plays a major role in the synthesis of glucans, which are important components of fungal cell walls, this observation offers a potential mechanism for the cell wall defects described for the pmt4 mutant strain [22]. Given the similar but distinct phenotypes of the pmt1 and pmt4 mutants, it is likely that these two Pmt proteins possess different affinities for Pmt target proteins.

Given the role that protein-O-glycosylation plays in microbial pathogenesis, investigators have explored Pmt proteins as potential targets for therapeutic intervention. Derivatives of rhodanine-3-acetic acid have recently been identified that specifically inhibit the Pmt1 isoform in C. albicans. Treating wild-type cells with these inhibitors resulted in phenotypic and transcriptional changes reminiscent of C. albicans pmt1 deletion strains [15], [50], [51]. Since Pmt2 and Pmt4 orthologs are present in mammals, the possibility of developing Pmt isoform-specific inhibitors renders Pmt proteins an attractive target for antifungal drug development. Additionally, targeting specific Pmt isoforms with inhibitory compounds may also be useful in killing phytopathogenic fungi, since Pmt proteins have yet to be identified in plants [3].

The cell wall defect in the pmt1 and pmt4 mutants is striking. One mechanism proposed for the Pmt4 control of C. neoformans cell wall integrity was recently provided. The stress related induction of the Fks1 gene, encoding the catalytic subunit of β-1,3-glucan synthase, is dependent on Pmt4 [22]. Since β-1,3-glucan is a major component of fungal cell walls, altered glucan synthesis would likely result in altered cell integrity under stress conditions [52]. Moreover, defects in C. neoformans PKC/cell integrity signalling resulted in phenotypes similar to those in the pmt mutant strains [53]. These phenotypes included morphological defects, defects in vacuolar biogenesis, growth defects at elevated growth temperatures or low SDS concentrations, and a higher sensitivity to osmotic stresses. Even more interesting it has been shown that proper PKC/cell integrity signalling is necessary for melanin production; pkc1 mutants show improper laccase localization and reduced melanin production. The cell wall abnormalities, and resulting changes in PKC signalling, may also explain the melanin production delay of the pmt4 mutants.

Levitz and Specht identified 55 potential GPI anchored membrane proteins with serine/threonine rich regions that are thought to be potential O-glycosylation targets [54]. Within these proteins there were several candidates that may be involved in remodelling the cell wall including three chitin-deacetylases (Cda1-3) and three potential endoglucanases (AAW45003, AAW46063 and AAW46065). It will be interesting to see whether any of these proteins will be identified as a direct target of Pmt-dependent O-glycosylation and if deletions of any of the corresponding genes will result in morphological phenotypes similar to the pmt mutants.

In conclusion, the PMT gene encodes a group of proteins critical in the biology and virulence of C. neoformans. Given the high degree of conservation in this gene family in other pathogenic fungi, this gene family is an ideal antifungal drug target. Future studies should explore this possibility and further define the mechanisms behind the PMT family mutant defects.

Materials and Methods

Strains and media

Reference strains used in this study where the congenic serotype D strains JEC20 (MATa) and JEC21 (MATα), and the serotype A strain H99. pmt mutant strains where constructed transforming the JEC20/21 derivatives JEC155 (MATα, ade2 ura5), JEC156 (MATa, ade2 ura5), or F99, respectively, a 5-FOA resistant derivative of H99. All strains used in this study are listed in Table 1. Yeast-peptone-dextrose (YPD) and yeast nitrogen base media, synthetic (SD) medium, V8 agar for mating, filament agar, Niger seed for melanin production, and serum-free Dulbecco's modified Eagle's medium for capsule induction were prepared as previously reported [32], [53], [55], [56].


Table 1. Strains used in this study.


Plasmid construction

PMT homologs were identified by tblastn searches using S. cerevisiae Pmt1 and C. albicans Pmt1 protein sequences against the National Center for Biotechnology Information ( For generating PMT disruption constructs PMT open reading frames (ORF) were amplified by PCR from reference strains H99 and JEC21, and fragments obtained were cloned into standard cloning vectors. Except for PMT1A BglII sites were integrated into the PMT ORFs using oligonucleotide based site directed mutagenesis (Stratagene Quick Change site directed mutagenesis kit). Subsequently, ADE2 or URA5 containing BamHI fragments were cloned into the BglII sites to disrupt the respective ORFs after amino acid E468 (2A), K461 (4A), W315 (1D), N508 (2D) and Q412 (4D), respectively. For PMT1A an existing EcoRV restriction site was used to generate the disruption constructs. In this case ADE2 and URA5 containing SmaI fragments were used for disrupting the PMT1A ORF at position D439. These constructs were then PCR amplified to generate a linear disruption allele and gel purified for use in biolistic transformation into appropriate auxotroph strain [57]. Biolistic transformations were conducted using established methods [58]. For reconstituting the generated disruption strains the PMT ORFs plus additional 500–700 bp up- and downstream of the respective START and STOP codons were amplified by PCR with primers containing BamHI restriction sites. Corresponding BamHI fragments were subsequently cloned into the BamHI restriction site of vector pJAF1 containing the Tn5 derived NeoR resistance marker [59].

The primers utilized in plasmid construction are presented in Table S1.

Strain construction

To generate a homozygous serotype D diploid ade2 strain, strains JEC156 and JEC157 were crossed according to Sia et al. (2000) and random spores were isolated on SD solid media supplemented with 20 µg/ml adenine. Plates were grown for several days at 37°C to prevent filament formation usually seen with diploid strains. In a second step, reddish Ade strains were isolated and re-streaked onto the same plates, but incubated at RT to induce filament and basidiospore formation typical of diploid Cryptococcus strains under these conditions. To generate a heterozygous pmt2/PMT2 serotype D strain, a resulting diploid ade2/ade2 diploid strain was transformed with an ADE2 based pmt2D-disruption construct using biolistic transformation. Heterozygous mutants were initially identified by colony PCR and subsequently confirmed by Southern analysis.

RNA preparation

Strains were incubated to mid-logarithmic phase at 30°C in YPD medium. Cells were collected by centrifugation and flash frozen on dry ice. Total RNA was extracted from lyophilized cells using the TRIzol reagent (Invitrogen Life Technologies, Carlsbad, CA).

Real-time PCR

Total RNA was isolated from the relevant strains as described above. The RNA was treated with RNase-free DNase, and cDNA was synthesized using oligo(dT) primers from the SuperScript first-strand synthesis reverse transcription kit (Invitrogen). The resulting cDNA was used as template for quantitative real-time PCR using iQ SYBR Green Supermix (Bio-Rad) according to the manufacturer's specifications. The iCycler iQ multicolor real-time detection system was used as the fluorescence detector with the following PCR conditions: an initial denaturing cycle of 95°C for 3 min and 40 cycles of denaturation at 95°C for 10 s and annealing/extension at 58°C for 330 s. These cycles were followed by a standard melting curve from 53°C to 93°C with fluorescent monitoring each 0.5°C. These data confirmed the amplification of a single product for each primer pair and the lack of primer dimerization. Reactions were performed in triplicate, and the data were expressed as an average cycle threshold, ± one standard deviation. Standard PCRs were run with fivefold dilutions of the cDNA template to determine the optimal amount of template and optimal annealing temperature for the experimental and reference reactions, using 500 nM of each primer.

Gene amplification for each strain and condition was normalized against the constitutively expressed GPD gene [60]. Induction (n-fold) was calculated relative to the wild-type strain JEC21 using the Bio-Rad iCycler software system, which utilizes the comparative cycle threshold statistical methods as previously described [61]

Mating analyses and haploid filamentation

To determine defects in mating, the various pmt mutant and tester strains were pre-grown on YPD plates at 30°C for 2–3 days, a small amount of growth was removed using a sterile tooth pick and spotted onto solid V8 plates (pH 5.0 or 7.0), either alone or mixed with a respective tester strain. Plates were incubated at room temperature (RT) in the dark for at least 3 days and mating and haploid filamentation was assessed by light microscopy.

Basidiospore isolation

To isolate basidiospores from genetic crosses, strains were crossed on solid V8 plates as has been described above for the mating analyses and incubated at RT in the dark until basidiospore formation was noticeable. Areas showing basidiospores were excised and single basidiospores were transferred to fresh YPD plates using a micromanipulator (single spore isolation). Alternatively, excised filaments were transferred to a 1.5 ml reaction tube containing 500 µl water, were vortexed vigorously, and spores were subsequently plated on fresh YPD plates or respective selective media (random spore isolation). To isolate haploid Ade2+ strains from the heterozygote serotype D pmt2/PMT2 strain a random spore analysis was done spreading spores on SD plates containing 20 µg/ml adenine, and plates were incubated at 37°C to prevent filamentation. Subsequently, only white colonies were re-streaked onto SD plates that were incubated at RT. Strains that would filament under these conditions were discarded since filamentation would indicate that these strains are still of diploid nature.

Serial dilution patch tests

Standard serial dilution patch tests were performed as follows: strains to be tested were pre-grown over night in 5 ml liquid YPD medium at 30°C into stationary phase. OD600 was determined the next day, cultures were diluted to an OD600 of 1, and tenfold serial dilutions were made in YPD down to a dilution of 10−4. Finally, 5 µl of the various dilutions were spotted onto the respective solid media and incubated at the indicated temperatures.


Light, DIC and fluorescence microscopy pictures were taken using a Zeiss Axioskop 2 Plus Fluorescence Microscope mounted with a AxioCam MRM digital camera, or alternatively with a Nikon Eclipse E400 microscope and a Nikon CoolPix 990 digital camera. Cell wall material and genomic DNA were stained using the Fluorescent Brightener 28 (calcofluor white; Sigma Aldrich) or 4,6-diamidinO-2-phenylindole (DAPI; Molecular Probes). First, C. neoformans strains were grown to an OD600 of ~1, cells were harvested and fixed for 30 min in 10% formaldehyde. Subsequently, cells were washed three times with PBS and then permeabilized with 1% Triton X-100 for 10 min. Finally, cells were once more washed three times with PBS and stained with the indicated dyes. To visualize vacuoles, cells were stained with the lipophilic dye N-(3-triethylammoniumpropyl)-4-(6-(4-(die​thylamino)phenyl) hexatrienyl) pyridinium dibromide (FM 4–64; T-3166; Invitrogen Corporation, Carlsbad, CA) as described previously [62], [63]. Briefly, logarithmically growing C. neoformans cells corresponding to 1 ml of OD600 of ~0.1 were harvested and resuspended in 100 µl YPD. Subsequently, the vacuolar stain FM4-64 was added to a final concentration of 40 µM, and cells were incubated on a rotary shaker for 45 min at 30°C. Before microscopy cells were washed several times with YPD.

In vitro virulence assays

To determine capsule production, strains of interest were grown over night in Dulbecco's modified Eagles medium for 3 days at 30°C [32]. Subsequently, 5 µl of the culture were mixed with an equal volume of India ink, and cells were analyzed by light microscopy. Melanin production was determined by two different techniques. First, 10 µl of over-night cultures were spotted onto standard Niger seed plates, and plates were incubated at 30°C for 2–4 days until the controls showed a brownish colour indicative of melanin production. Second, cells from 25 ml YPD over-night cultures were harvested and resuspended in 2 ml of glucose-free asparagine-medium supplemented with L-DOPA, and cell suspensions were incubated for 24 h at 30°C on a rotary shaker. Subsequently cells were pelleted, and melanin production was documented by photographing the cell pellet, and determining the OD480 of the supernatants [64]. Urease activity tests on wild-type and pmt mutant strains were performed in the following way. One colony of each strain was added to sterile deionized H2O in a microcentrifuge tube and vortexed vigorously. One BBL TAXO™ urease differentiation disk (Becton, Dickinson, & Co., Sparks, MD) was added to each tube using sterile techniques, which then were incubated at 30°C and checked at 10 min and 30 min for urease activity according to manufacturer's instructions.

In vivo virulence analyses

Overall virulence of C. neoformans strains was tested by macrophage killing assays and by a murine inhalation model. For the macrophage killing assay 50 µl of freshly grown J77A.1 macrophages (~1×105 J774A.1 macrophages in DMEM) were pipetted into 96 well microtiter plates and activated by adding 50 µl DMEM supplemented with INF-γ (100 U/ml) and LPS (0.6 µg/ml). Negative controls were “activated” with DMEM containing no additional supplements. Microtiter plates were then incubated for 12–18 h at 37°C under a 5% CO2 atmosphere to generate a macrophage cell-layer. C. neoformans strains to be tested were grown over night in liquid YPD medium, cells were harvested and washed three times with PBS. Cells were resuspended in DMEM containing 1 µg/ml monoclonal antibody mAb18B7 at a cell titer of 1×106 living cells per ml, determined by Trypan Blue staining, and incubated for 1 h at 37°C at 5% CO2. Subsequently, 100 µl C. neoformans cells were pipetted on top of the macrophage cell layers, and microtiter plates were incubated at 37°C at 5% CO2 for one hour. Non incorporated cryptococcal cells were removed by carefully washing the macrophage cell layers three times with PBS. Finally cell layers were covered with 150 µl fresh DMEM culture medium and incubated for another 24 h at 37°C at 5% CO2. To determine survival rates of cryptococcal cells the covering culture medium was removed and transferred to a fresh reaction tube. Macrophages in the titer plates were incubated with 100 µl 0.5% SDS solution for ~5 min at RT, cells were lysed by pipetting cells up and down several times, and the cell lysate was combined with its respective culture supernatant. Finally, wells were washed once with 200 µl PBS solution, which was subsequently added to the respective cell lysate. Cell lysates were diluted 300 fold, and cryptococcal CFU were determined by standard techniques on solid YPD plates, incubated at 30°C. Macrophage killing assays were repeated at least three times [65]. The murine inhalation model of systemic Cryptococcosis was performed as described before [66]. Briefly, groups of ten female A/Jcr mice (~20 g body weight) were infected intra-nasally with 105 cryptococcal CFU resuspended in PBS. To determine survival rates, mice were inspected for vitality twice a day, and individuals showing ~15% weight loss, neurological abnormalities or extreme anorexia were sacrificed immediately according to the animal protection regulations of the Duke University Medical Center Animal Care & Use Program. Mice were maintained at the Research Institute for Children Animal Facility in accordance with the American Association of Accreditation of Laboratory Animal Care guidelines.

Statistical analysis

The software program Prism 5 (GraphPad, San Diego, Calif.) was used for all statistical tests. Log-rank tests were utilized to determine significance of survival in animal studies.

Supporting Information

Table S1.

Plasmids used in this study


(0.02 MB XLS)


We wish to thank J. Heitman for providing C. neoformans strains and plasmids. A special thanks to all the members of the Ernst/Lengeler, Alspaugh laboratories and Robert Cramer for technical assistance and helpful discussion.

Author Contributions

Conceived and designed the experiments: SDW AA KL. Performed the experiments: SDW. Analyzed the data: SDW. Contributed reagents/materials/analysis tools: JE AA KL. Wrote the paper: SDW AA KL.


  1. 1. Tanner W, Lehle L (1987) Protein glycosylation in yeast. Biochim Biophys Acta 906: 81–99.
  2. 2. Strahl-Bolsinger S, Gentzsch M, Tanner W (1999) Protein O-mannosylation. Biochim Biophys Acta 1426: 297–307.
  3. 3. Ernst JF, Prill SK (2001) O-glycosylation. Med Mycol 39: Suppl 167–74.
  4. 4. Jurado LA, Coloma A, Cruces J (1999) Identification of a human homolog of the Drosophila rotated abdomen gene (POMT1) encoding a putative protein O-mannosyl-transferase, and assignment to human chromosome 9q34.1. Genomics 58: 171–180.
  5. 5. Willer T, Amselgruber W, Deutzmann R, Strahl S (2002) Characterization of POMT2, a novel member of the PMT protein O-mannosyltransferase family specifically localized to the acrosome of mammalian spermatids. Glycobiology 12: 771–783.
  6. 6. Lyalin D, Koles K, Roosendaal SD, Repnikova E, Van Wechel L, et al. (2006) The twisted gene encodes Drosophila protein O-mannosyltransferase 2 and genetically interacts with the rotated abdomen gene encoding Drosophila protein O-mannosyltransferase 1. Genetics 172: 343–353.
  7. 7. VanderVen BC, Harder JD, Crick DC, Belisle JT (2005) Export-mediated assembly of mycobacterial glycoproteins parallels eukaryotic pathways. Science 309: 941–943.
  8. 8. Mahne M, Tauch A, Puhler A, Kalinowski J (2006) The Corynebacterium glutamicum gene pmt encoding a glycosyltransferase related to eukaryotic protein-O-mannosyltransferases is essential for glycosylation of the resuscitation promoting factor (Rpf2) and other secreted proteins. FEMS Microbiol Lett 259: 226–233.
  9. 9. Strahl-Bolsinger S, Scheinost A (1999) Transmembrane topology of pmt1p, a member of an evolutionarily conserved family of protein O-mannosyltransferases. J Biol Chem 274: 9068–9075.
  10. 10. Willer T, Valero MC, Tanner W, Cruces J, Strahl S (2003) O-mannosyl glycans: from yeast to novel associations with human disease. Curr Opin Struct Biol 13: 621–630.
  11. 11. Gentzsch M, Tanner W (1997) Protein-O-glycosylation in yeast: protein-specific mannosyltransferases. Glycobiology 7: 481–486.
  12. 12. Bourdineaud JP, van der Vaart JM, Donzeau M, de Sampaio G, Verrips CT, et al. (1998) Pmt1 mannosyl transferase is involved in cell wall incorporation of several proteins in Saccharomyces cerevisiae. Mol Microbiol 27: 85–98.
  13. 13. Harty C, Strahl S, Romisch K (2001) O-mannosylation protects mutant alpha-factor precursor from endoplasmic reticulum-associated degradation. Mol Biol Cell 12: 1093–1101.
  14. 14. Proszynski TJ, Simons K, Bagnat M (2004) O-glycosylation as a sorting determinant for cell surface delivery in yeast. Mol Biol Cell 15: 1533–1543.
  15. 15. Prill SK, Klinkert B, Timpel C, Gale CA, Schroppel K, et al. (2005) PMT family of Candida albicans: five protein mannosyltransferase isoforms affect growth, morphogenesis and antifungal resistance. Mol Microbiol 55: 546–560.
  16. 16. Lommel M, Bagnat M, Strahl S (2004) Aberrant processing of the WSC family and Mid2p cell surface sensors results in cell death of Saccharomyces cerevisiae O-mannosylation mutants. Mol Cell Biol 24: 46–57.
  17. 17. Beltran-Valero de Bernabe D, Currier S, Steinbrecher A, Celli J, van Beusekom E, et al. (2002) Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. Am J Hum Genet 71: 1033–1043.
  18. 18. Willer T, Prados B, Falcon-Perez JM, Renner-Muller I, Przemeck GK, et al. (2004) Targeted disruption of the Walker-Warburg syndrome gene Pomt1 in mouse results in embryonic lethality. Proc Natl Acad Sci U S A 101: 14126–14131.
  19. 19. Martin-Blanco E, Garcia-Bellido A (1996) Mutations in the rotated abdomen locus affect muscle development and reveal an intrinsic asymmetry in Drosophila. Proc Natl Acad Sci U S A 93: 6048–6052.
  20. 20. Ichimiya T, Manya H, Ohmae Y, Yoshida H, Takahashi K, et al. (2004) The twisted abdomen phenotype of Drosophila POMT1 and POMT2 mutants coincides with their heterophilic protein O-mannosyltransferase activity. J Biol Chem 279: 42638–42647.
  21. 21. Perfect JR, Casadevall A (2002) Cryptococcosis. Infect Dis Clin North Am 16: 837–874, v–vi.
  22. 22. Olson GM, Fox DS, Wang P, Alspaugh JA, Buchanan KL (2007) Role of protein O-mannosyltransferase Pmt4 in the morphogenesis and virulence of Cryptococcus neoformans. Eukaryot Cell 6: 222–234.
  23. 23. Loftus BJ, Fung E, Roncaglia P, Rowley D, Amedeo P, et al. (2005) The genome of the basidiomycetous yeast and human pathogen Cryptococcus neoformans. Science 307: 1321–1324.
  24. 24. Franzot SP, Fries BC, Cleare W, Casadevall A (1998) Genetic relationship between Cryptococcus neoformans var. neoformans strains of serotypes A and D. J Clin Microbiol 36: 2200–2204.
  25. 25. Tanaka R, Imanishi Y, Nishimura K (2003) Difference in FKS1 gene sequences between serotypes A and D of Cryptococcus neoformans. J Clin Microbiol 41: 4457–4459.
  26. 26. Sugita T, Ikeda R, Shinoda T (2001) Diversity among strains of Cryptococcus neoformans var. gattii as revealed by a sequence analysis of multiple genes and a chemotype analysis of capsular polysaccharide. Microbiol Immunol 45: 757–768.
  27. 27. Girrbach V, Zeller T, Priesmeier M, Strahl-Bolsinger S (2000) Structure-function analysis of the dolichyl phosphate-mannose: protein O-mannosyltransferase ScPmt1p. J Biol Chem 275: 19288–19296.
  28. 28. Willer T, Brandl M, Sipiczki M, Strahl S (2005) Protein O-mannosylation is crucial for cell wall integrity, septation and viability in fission yeast. Mol Microbiol 57: 156–170.
  29. 29. Sia RA, Lengeler KB, Heitman J (2000) Diploid strains of the pathogenic basidiomycete Cryptococcus neoformans are thermally dimorphic. Fungal Genet Biol 29: 153–163.
  30. 30. Girrbach V, Strahl S (2003) Members of the evolutionarily conserved PMT family of protein O-mannosyltransferases form distinct protein complexes among themselves. J Biol Chem 278: 12554–12562.
  31. 31. Akasaka-Manya K, Manya H, Nakajima A, Kawakita M, Endo T (2006) Physical and functional association of human protein O-mannosyltransferases 1 and 2. J Biol Chem 281: 19339–19345.
  32. 32. Granger DL, Perfect JR, Durack DT (1985) Virulence of Cryptococcus neoformans: regulation of capsule synthesis by carbon dioxide. J Clin Invest 76: 508–516.
  33. 33. Kwon-Chung KJ, Edman JC, Wickes BL (1992) Genetic association of mating types and virulence in Cryptococcus neoformans. Infect Immun 60: 602–605.
  34. 34. Nielsen K, Cox GM, Wang P, Toffaletti DL, Perfect JR, et al. (2003) Sexual cycle of Cryptococcus neoformans var. grubii and virulence of congenic a and alpha isolates. Infect Immun 71: 4831–4841.
  35. 35. Shaw BD, Momany M (2002) Aspergillus nidulans polarity mutant swoA is complemented by protein O-mannosyltransferase pmtA. Fungal Genet Biol 37: 263–270.
  36. 36. Gentzsch M, Tanner W (1996) The PMT gene family: protein O-glycosylation in Saccharomyces cerevisiae is vital. Embo J 15: 5752–5759.
  37. 37. Rouabhia M, Schaller M, Corbucci C, Vecchiarelli A, Prill SK, et al. (2005) Virulence of the fungal pathogen Candida albicans requires the five isoforms of protein mannosyltransferases. Infect Immun 73: 4571–4580.
  38. 38. Gentzsch M, Immervoll T, Tanner W (1995) Protein O-glycosylation in Saccharomyces cerevisiae: the protein O-mannosyltransferases Pmt1p and Pmt2p function as heterodimer. FEBS Lett 377: 128–130.
  39. 39. Rhodes JC, Polacheck I, Kwon-Chung KJ (1982) Phenoloxidase activity and virulence in isogenic strains of Cryptococcus neoformans. Infect Immun 36: 1175–1184.
  40. 40. Kwon-Chung KJ, Polacheck I, Popkin TJ (1982) Melanin-lacking mutants of Cryptococcus neoformans and their virulence for mice. J Bacteriol 150: 1414–1421.
  41. 41. Chang YC, Kwon-Chung KJ (1994) Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence. Mol Cell Biol 14: 4912–4919.
  42. 42. Chen SC, Muller M, Zhou JZ, Wright LC, Sorrell TC (1997) Phospholipase activity in Cryptococcus neoformans: a new virulence factor? J Infect Dis 175: 414–420.
  43. 43. Chen SC, Wright LC, Santangelo RT, Muller M, Moran VR, et al. (1997) Identification of extracellular phospholipase B, lysophospholipase, and acyltransferase produced by Cryptococcus neoformans. Infect Immun 65: 405–411.
  44. 44. Zhu X, Gibbons J, Garcia-Rivera J, Casadevall A, Williamson PR (2001) Laccase of Cryptococcus neoformans is a cell wall-associated virulence factor. Infect Immun 69: 5589–5596.
  45. 45. Li L, Zaragoza O, Casadevall A, Fries BC (2006) Characterization of a flocculation-like phenotype in Cryptococcus neoformans and its effects on pathogenesis. Cell Microbiol 8: 1730–1739.
  46. 46. Heitman J, Filler SG, Mitchell AP (2006) Molecular principles of fungal pathogenesis. Washington, D.C.: ASM Press.
  47. 47. Pietrella D, Corbucci C, Perito S, Bistoni G, Vecchiarelli A (2005) Mannoproteins from Cryptococcus neoformans promote dendritic cell maturation and activation. Infect Immun 73: 820–827.
  48. 48. Murphy JW (1988) Influence of cryptococcal antigens on cell-mediated immunity. Rev Infect Dis 10: Suppl 2S432–435.
  49. 49. Mansour MK, Schlesinger LS, Levitz SM (2002) Optimal T cell responses to Cryptococcus neoformans mannoprotein are dependent on recognition of conjugated carbohydrates by mannose receptors. J Immunol 168: 2872–2879.
  50. 50. Cantero PD, Lengsfeld C, Prill SK, Subanovic M, Roman E, et al. (2007) Transcriptional and physiological adaptation to defective protein-O-mannosylation in Candida albicans. Mol Microbiol 64: 1115–1128.
  51. 51. Orchard MG, Neuss JC, Galley CM, Carr A, Porter DW, et al. (2004) Rhodanine-3-acetic acid derivatives as inhibitors of fungal protein mannosyl transferase 1 (PMT1). Bioorg Med Chem Lett 14: 3975–3978.
  52. 52. Thompson JR, Douglas CM, Li W, Jue CK, Pramanik B, et al. (1999) A glucan synthase FKS1 homolog in cryptococcus neoformans is single copy and encodes an essential function. J Bacteriol 181: 444–453.
  53. 53. Gerik KJ, Donlin MJ, Soto CE, Banks AM, Banks IR, et al. (2005) Cell wall integrity is dependent on the PKC1 signal transduction pathway in Cryptococcus neoformans. Mol Microbiol 58: 393–408.
  54. 54. Levitz SM, Specht CA (2006) The molecular basis for the immunogenicity of Cryptococcus neoformans mannoproteins. FEMS Yeast Res 6: 513–524.
  55. 55. Alspaugh JA, Perfect JR, Heitman J (1997) Cryptococcus neoformans mating and virulence are regulated by the G-protein alpha subunit GPA1 and cAMP. Genes Dev 11: 3206–3217.
  56. 56. Vartivarian SE, Anaissie EJ, Cowart RE, Sprigg HA, Tingler MJ, et al. (1993) Regulation of cryptococcal capsular polysaccharide by iron. J Infect Dis 167: 186–190.
  57. 57. Davidson RC, Blankenship JR, Kraus PR, de Jesus Berrios M, Hull CM, et al. (2002) A PCR-based strategy to generate integrative targeting alleles with large regions of homology. Microbiology 148: 2607–2615.
  58. 58. Toffaletti DL, Perfect JR (1994) Biolistic DNA delivery for Cryptococcus neoformans transformation. In: Maresca B, Kobayashi GS, editors. Molecular Biology of Pathogenic Fungal: A Laboratory Manual. New York: Telos Press. pp. 303–308.
  59. 59. Fraser JA, Subaran RL, Nichols CB, Heitman J (2003) Recapitulation of the sexual cycle of the primary fungal pathogen Cryptococcus neoformans var. gattii: implications for an outbreak on Vancouver Island, Canada. Eukaryot Cell 2: 1036–1045.
  60. 60. Varma A, Kwon-Chung KJ (1999) Characterization of the glyceraldehyde-3-phosphate dehydrogenase gene and the use of its promoter for heterologous expression in Cryptococcus neoformans, a human pathogen. Gene 232: 155–163.
  61. 61. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: RESEARCH0034.
  62. 62. Vida TA, Emr SD (1995) A new vital stain for visualizing vacuolar membrane dynamics and endocytosis in yeast. J Cell Biol 128: 779–792.
  63. 63. Wang YX, Zhao H, Harding TM, Gomes de Mesquita DS, Woldringh CL, et al. (1996) Multiple classes of yeast mutants are defective in vacuole partitioning yet target vacuole proteins correctly. Mol Biol Cell 7: 1375–1389.
  64. 64. Pukkila-Worley R, Gerrald QD, Kraus PR, Boily MJ, Davis MJ, et al. (2005) Transcriptional network of multiple capsule and melanin genes governed by the Cryptococcus neoformans cyclic AMP cascade. Eukaryot Cell 4: 190–201.
  65. 65. McDade HC, Cox GM (2001) A new dominant selectable marker for use in Cryptococcus neoformans. Med Mycol 39: 151–154.
  66. 66. Wang P, Cutler J, King J, Palmer D (2004) Mutation of the regulator of G protein signaling Crg1 increases virulence in Cryptococcus neoformans. Eukaryot Cell 3: 1028–1035.
  67. 67. Toffaletti DL, Rude TH, Johnston SA, Durack DT, Perfect JR (1993) Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNA. J Bacteriol 175: 1405–1411.
  68. 68. Heitman J, Allen B, Alspaugh JA, Kwon-Chung KJ (1999) On the origins of congenic MATalpha and MATa strains of the pathogenic yeast Cryptococcus neoformans. Fungal Genet Biol 28: 1–5.